Central Proteina Valuation
| CPRO Stock | IDR 50.00 0.00 0.00% |
At this time, the firm appears to be fairly valued. Central Proteina Prima shows a prevailing Real Value of 50.75 per share. The current price of the firm is 50.0. Our model approximates the value of Central Proteina Prima from analyzing the firm fundamentals such as Current Valuation of 5.48 T, profit margin of 0.05 %, and Return On Equity of 0.13 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Central Proteina's price fluctuation is very steady at this time. Calculation of the real value of Central Proteina Prima is based on 3 months time horizon. Increasing Central Proteina's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Central Proteina's intrinsic value may or may not be the same as its current market price of 50.00, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 50.0 | Real 50.75 | Hype 50.0 | Naive 50.46 |
The intrinsic value of Central Proteina's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Central Proteina's stock price.
Estimating the potential upside or downside of Central Proteina Prima helps investors to forecast how Central stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Central Proteina more accurately as focusing exclusively on Central Proteina's fundamentals will not take into account other important factors: Central Proteina Total Value Analysis
Central Proteina Prima is currently forecasted to have takeover price of 5.48 T with market capitalization of 3.1 T, debt of 1.06 T, and cash on hands of 158.78 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Central Proteina fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.48 T | 3.1 T | 1.06 T | 158.78 B |
Central Proteina Investor Information
About 49.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.02. Some equities with similar Price to Book (P/B) outperform the market in the long run. Central Proteina Prima recorded earning per share (EPS) of 6.3. The entity had not issued any dividends in recent years. Based on the key measurements obtained from Central Proteina's financial statements, Central Proteina Prima is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Central Proteina Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Central Proteina has an asset utilization ratio of 124.5 percent. This suggests that the Company is making 1.25 for each dollar of assets. An increasing asset utilization means that Central Proteina Prima is more efficient with each dollar of assets it utilizes for everyday operations.Central Proteina Ownership Allocation
Central Proteina holds a total of 40.47 Billion outstanding shares. Central Proteina Prima retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Central Proteina Profitability Analysis
The company reported the revenue of 8.03 T. Net Income was 2.21 T with profit before overhead, payroll, taxes, and interest of 1.51 T.About Central Proteina Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Central Proteina Prima. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Central Proteina Prima based exclusively on its fundamental and basic technical indicators. By analyzing Central Proteina's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Central Proteina's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Central Proteina. We calculate exposure to Central Proteina's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Central Proteina's related companies.PT Central Proteina Prima Tbk, together with its subsidiaries, operates as an integrated aquaculture company in Indonesia and internationally. PT Central Proteina Prima Tbk was founded in 1980 and is headquartered in Jakarta Selatan, Indonesia. Central Proteina operates under Farm Products classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 1780 people.
8 Steps to conduct Central Proteina's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Central Proteina's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Central Proteina's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Central Proteina's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Central Proteina's revenue streams: Identify Central Proteina's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Central Proteina's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Central Proteina's growth potential: Evaluate Central Proteina's management, business model, and growth potential.
- Determine Central Proteina's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Central Proteina's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in Central Stock
Central Proteina financial ratios help investors to determine whether Central Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Central with respect to the benefits of owning Central Proteina security.